Brandes Amplifies Grifols Stake as Investors Expect Brookfield Offer

In a strategic move that has captured the attention of the investment community, Brandes Investment Partners has significantly increased its ownership in Grifols S.A., the Spanish pharmaceutical company specialized in plasma-derived therapies. This decision comes at a time when investors are keenly anticipating a potential bid from Brookfield Asset Management, a global investment powerhouse known for its vast portfolio and strategic acquisitions.

Continue reading